Bombay High Court Halts ₹17.68 Cr GST Demand Against Religare Subsidiary

Care Health Insurance (CHIL), a subsidiary of Religare Enterprises, has received a stay order from the Bombay High Court. The court halted a Goods and Services Tax (GST) demand and penalty totaling ₹17.68 crore. The order relates to Special Economic Zone (SEZ) matters for the financial years 2017-18 through 2023-24, and is in effect until the court resolves the related writ petition.

High Court Grants Stay on Tax Demand

Care Health Insurance Limited (CHIL), a key subsidiary of Religare Enterprises Limited (REL), has obtained a stay order from the Bombay High Court. The stay halts a previous order that imposed a Goods and Services Tax (GST) demand and penalty of ₹17,68,26,837 (₹17.68 crore). This demand stemmed from a tax authority's assessment for Special Economic Zone (SEZ) matters covering the period from July 2017 to March 2024. This relief will remain in place until the final decision on the writ petition CHIL filed to challenge the tax authority's demand.

Financial Relief and Legal Challenge

The stay provides Care Health Insurance with significant temporary financial relief by halting the substantial tax demand. This eases immediate cash outflow pressure, allowing CHIL to focus on operations while its legal challenge proceeds. The ruling also highlights the complexities of GST application, especially for entities involved with Special Economic Zones (SEZs). The company is now temporarily free from paying the ₹17.68 crore demand and penalty, preserving financial resources for strategic planning and operations until the court makes its final decision.

Tax Disputes in the Insurance Sector

Religare Enterprises offers a range of financial services, with its health insurance arm, Care Health Insurance, being a key part of its business. The Indian insurance sector has faced similar tax disputes. For instance, in January 2026, the Bombay High Court granted a stay on GST demands totaling over ₹10,000 crore to 13 insurance companies concerning co-insurance premiums and ceding commissions. This suggests a wider pattern of regulatory scrutiny and legal challenges related to GST interpretations within the insurance industry. Care Health Insurance also faced a separate ₹1 crore penalty from IRDAI in January 2026.

Potential Future Liabilities

The primary risk for CHIL is the final outcome of the writ petition. If the court rules against the company, the GST demand and penalty, along with applicable interest, may still need to be paid. The 'industry-wide' aspect of the SEZ matter implies other companies in similar positions could face comparable demands if tax authorities are successful in their arguments. Ongoing litigation can divert management attention and raise reputational concerns, even with a temporary stay.

Industry-Wide Tax Issues

Care Health Insurance competes with major players like Star Health and Allied Insurance, ICICI Lombard General Insurance, and HDFC ERGO General Insurance. Several of these peers, including Aditya Birla Health Insurance and SBI General Insurance, were among the 13 insurers that obtained a ₹10,000 crore GST demand stay from the Bombay High Court in January 2026. This highlights the prevalence of such tax disputes across the insurance sector.

Next Steps

Investors and stakeholders will be tracking the progress and final verdict of the writ petition filed by CHIL at the Bombay High Court. Any further court directives or interim orders during the petition's proceedings will also be significant. CHIL's strategic and financial planning as the legal proceedings continue will be key. Additionally, any broader regulatory or judicial rulings on SEZ-related GST matters that might affect the sector will be closely watched.